rheumatoid arthritis dmard vs biologic Updated American College of Rheumatology recommendations suggest using first-line DMARDs in combination with biologic agents and nonbiologic DMARDs to achieve ...
DMARDs are a medication that suppresses the immune system. People may take them to slow disease progression in autoimmune or inflammatory conditions, such as different types of arthritis. Inflammation ...
Since their first publication in 2010, the EULAR recommendations for the use of disease-modifying anti-rheumatic treatments (DMARDs) in people with RA have become a most important publication in the ...
Ankylosing spondylitis is a type of arthritis that inflames joints of the spine and leaves your back stiff and painful. If nonsteroidal anti-inflammatory drugs (NSAIDs) aren't enough to relieve your ...
Rheumatoid arthritis (RA) is an autoimmune condition in which the immune system attacks the lining of the joints. Traditional and biologic disease-modifying antirheumatic drugs (DMARDs) are two forms ...
Most people start a disease modifying antirheumatic drug (DMARD), such as methotrexate, soon after RA diagnosis. If you're still adjusting to a DMARD or want to better understand how it slows joint ...
A treat-to-target approach appears feasible in patients with elderly-onset rheumatoid arthritis, with similar disease control ...
After the first 6 months of disease-modifying antirheumatic drugs (DMARDs) use in patients with rheumatoid arthritis (RA), most very abnormal results newly seen in long-term routine laboratory ...
Only slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year. Objectives: To determine the rate of timely disease-modifying antirheumatic drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results